BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21724445)

  • 1. Bone turnover markers for osteoporotic status assessment? A systematic review of their diagnosis value at baseline in osteoporosis.
    Biver E; Chopin F; Coiffier G; Brentano TF; Bouvard B; Garnero P; Cortet B
    Joint Bone Spine; 2012 Jan; 79(1):20-5. PubMed ID: 21724445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort.
    Yoshimura N; Muraki S; Oka H; Kawaguchi H; Nakamura K; Akune T
    Mod Rheumatol; 2011 Dec; 21(6):608-20. PubMed ID: 21512822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic of bone turnover markers after osteoporotic vertebral compression fractures in postmenopausal female.
    Pan C; Liu X; Li T; Wang G; Sun J
    J Orthop Surg Res; 2018 Dec; 13(1):314. PubMed ID: 30526635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical Markers of Bone Turnover and their Role in Osteoporosis Diagnosis: A Narrative Review.
    Khashayar P; Meybodi HA; Amoabediny G; Larijani B
    Recent Pat Endocr Metab Immune Drug Discov; 2015; 9(2):79-89. PubMed ID: 26246012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Traditional and novel bone remodeling markers in premenopausal and postmenopausal women.
    Botella S; Restituto P; Monreal I; Colina I; Calleja A; Varo N
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1740-8. PubMed ID: 24001743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk].
    Mohamed Y; Haifa H; Datel O; Fadoua HN; Smeh BH; Mahbouba J; Saoussen Z; Bejia I; Mongi T; Mohamed FN; Naceur B
    Tunis Med; 2014 May; 92(5):304-10. PubMed ID: 25504382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis.
    Mederle OA; Balas M; Ioanoviciu SD; Gurban CV; Tudor A; Borza C
    Clin Interv Aging; 2018; 13():1383-1389. PubMed ID: 30122910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monitoring anti-osteoporotic therapy: bone mineral density or markers of bone turnover].
    Pedersen SB; Rand MS; Eiken PA; Jørgensen NR
    Ugeskr Laeger; 2018 Aug; 180(32):. PubMed ID: 30070630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
    Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone Turnover Marker Profiling and Fracture Risk in Older Women: Fracture Risk from Age 75 to 90.
    Ivaska KK; McGuigan FE; Malmgren L; Gerdhem P; Johansson H; Kanis JA; Akesson KE
    Calcif Tissue Int; 2022 Sep; 111(3):288-299. PubMed ID: 35750934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
    Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of biochemical markers in the management of osteoporosis.
    Henriksen K; Christiansen C; Karsdal MA
    Climacteric; 2015; 18 Suppl 2():10-8. PubMed ID: 26507704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of bone turnover to bone density and fractures.
    Melton LJ; Khosla S; Atkinson EJ; O'Fallon WM; Riggs BL
    J Bone Miner Res; 1997 Jul; 12(7):1083-91. PubMed ID: 9200008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
    Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
    J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical usefulness of bone turnover markers with the treatment of osteoporosis].
    Miura M
    Clin Calcium; 2014 Mar; 24(3):367-76. PubMed ID: 24576933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone turnover markers in postmenopausal osteoporosis and their correlation with bone mineral density and menopause duration.
    Gurban CV; Balaş MO; Vlad MM; Caraba AE; Jianu AM; Bernad ES; Borza C; Bănicioiu-Covei S; Motoc AGM
    Rom J Morphol Embryol; 2019; 60(4):1127-1135. PubMed ID: 32239087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone Turnover Markers: Use in Fracture Prediction.
    Vilaca T; Gossiel F; Eastell R
    J Clin Densitom; 2017; 20(3):346-352. PubMed ID: 28716498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
    Verit FF; Geyikli I; Yazgan P; Celik A
    Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone turnover markers: understanding their value in clinical trials and clinical practice.
    Civitelli R; Armamento-Villareal R; Napoli N
    Osteoporos Int; 2009 Jun; 20(6):843-51. PubMed ID: 19190842
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.